help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barker, J. N.
Right arrow Articles by MacDonald, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barker, J. N.
Right arrow Articles by MacDonald, D. M.

American Journal of Pathology, Vol 142, 1091-1097, Copyright © 1993 by American Society for Investigative Pathology


REGULAR ARTICLES

Increased epidermal cell proliferation in normal human skin in vivo following local administration of interferon-gamma

JN Barker, JR Goodlad, EL Ross, CC Yu, RW Groves and DM MacDonald
Laboratory of Applied Dermatopathology, St. John's Institute of Dermatology Guy's Campus, London, United Kingdom.

Recombinant human interferon-gamma was administered intradermally (10 micrograms in 0.1 ml) to healthy adult human volunteers from day 1 to day 3, and epidermal cell proliferation was measured on whole skin biopsies at day 6. Three independent parameters were assessed, namely, a) epidermal keratin-16 expression, b) keratinocyte proliferating cell nuclear antigen expression, and c) keratinocyte silver nucleolar organizer region counts. Significantly increased scores for each parameter were observed after interferon-gamma injection (P < 0.01 in each case) compared to site-matched controls. Keratin-16 expression was confined to suprabasal epidermis, whereas proliferating cell nuclear antigen and silver nucleolar organizer region counts were particularly elevated in the basal epidermis. Taken together with previous findings, these studies indicate both proinflammatory and growth regulatory roles for interferon-gamma in human skin. These data are likely to be of particular importance to pathophysiological mechanisms of psoriasis and related cutaneous inflammatory diseases.


This article has been cited by other articles:


Home page
Arch DermatolHome page
I. B. Walters, M. Ozawa, I. Cardinale, P. Gilleaudeau, W. L. Trepicchio, J. Bliss, and J. G. Krueger
Narrowband (312-nm) UV-B Suppresses Interferon {gamma} and Interleukin (IL) 12 and Increases IL-4 Transcripts: Differential Regulation of Cytokines at the Single-Cell Level
Arch Dermatol, February 1, 2003; 139(2): 155 - 161.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S.-H. CHEN, I. ARANY, N. APISARNTHANARAX, S. RAJARAMAN, S. K. TYRING, T. HORIKOSHI, H. BRYSK, and M. M. BRYSK
Response of keratinocytes from normal and psoriatic epidermis to interferon-{gamma} differs in the expression of zinc-{alpha}2-glycoprotein and cathepsin D
FASEB J, March 1, 2000; 14(3): 565 - 571.
[Abstract] [Full Text]


Home page
FASEB J.Home page
M. JACKSON, S. E. M. HOWIE, R. WELLER, E. SABIN, J. A. A. HUNTER, and R. C. McKENZIE
Psoriatic keratinocytes show reduced IRF-1 and STAT-1{alpha} activation in response to {gamma}-IFN
FASEB J, March 1, 1999; 13(3): 495 - 502.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.